Liquidia Corp (LQDA)
10.15
+0.03
(+0.30%)
USD |
NASDAQ |
Nov 21, 16:00
10.16
+0.01
(+0.10%)
After-Hours: 20:00
Liquidia Gross Profit Margin (Quarterly): 64.82% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 64.82% |
June 30, 2024 | 59.20% |
March 31, 2024 | 50.64% |
December 31, 2023 | 78.08% |
September 30, 2023 | 84.50% |
June 30, 2023 | 85.98% |
March 31, 2023 | 85.44% |
December 31, 2022 | 87.05% |
September 30, 2022 | 76.62% |
June 30, 2022 | 81.34% |
March 31, 2022 | 80.13% |
December 31, 2021 | 77.42% |
September 30, 2021 | 72.00% |
June 30, 2021 | 78.85% |
March 31, 2021 | 77.50% |
December 31, 2020 | 67.86% |
Date | Value |
---|---|
September 30, 2020 | |
June 30, 2020 | |
March 31, 2020 | |
December 31, 2019 | |
September 30, 2019 | |
June 30, 2019 | 90.00% |
March 31, 2019 | |
December 31, 2018 | |
September 30, 2018 | |
June 30, 2018 | 90.95% |
March 31, 2018 | 97.08% |
December 31, 2017 | 95.60% |
September 30, 2017 | 95.61% |
June 30, 2017 | 95.97% |
March 31, 2017 | 95.12% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
50.64%
Minimum
Mar 2024
87.05%
Maximum
Dec 2022
75.46%
Average
77.79%
Median
Gross Profit Margin (Quarterly) Benchmarks
United Therapeutics Corp | 88.90% |
Arcturus Therapeutics Holdings Inc | -- |
Paragon 28 Inc | 74.08% |
Tonix Pharmaceuticals Holding Corp | 44.90% |
AIM ImmunoTech Inc | 77.14% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Equity | -168.4% |
Return on Assets | -69.68% |
Return on Invested Capital | -168.4% |
Profit Margin (Quarterly) | -520.6% |
Operating Margin (Quarterly) | -656.2% |
Return on Net Operating Assets | -590.9% |